Therapeutic hope for psoriasis offered by SOCS (suppressor of cytokine signaling) mimetic peptide (Q45780399)

16 December 2017

title

Therapeutic hope for psoriasis offered by SOCS (suppressor of cytokine signaling) mimetic peptide (English)

1 reference

16 December 2017

author name string

Masato Kubo

series ordinal

1

1 reference

16 December 2017

language of work or name

English

0 references

publication date

1 July 2013

1 reference

16 December 2017

European Journal of Immunology

published in

1 reference

16 December 2017

volume

43

1 reference

16 December 2017

issue

7

1 reference

16 December 2017

page(s)

1702-1705

1 reference

16 December 2017

Pattern recognition receptors and inflammation

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343748

Psoriatic scales: a promising source for the isolation of human skin-derived antimicrobial proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343748

Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343748

NF-κB in the regulation of epithelial homeostasis and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343748

The interleukin-6 cytokine system regulates epidermal permeability barrier homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343748

Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343748

Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343748

Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343748

Therapeutical potential of a peptide mimicking the SOCS1 kinase inhibitory region in skin immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343748

SOCS proteins, cytokine signalling and immune regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343748

The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343748

Suppressors of cytokine signaling and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343748

Impaired IFN-gamma-dependent inflammatory responses in human keratinocytes overexpressing the suppressor of cytokine signaling 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343748

Suppressor of cytokine signaling in allergic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343748

Dysregulation of suppressor of cytokine signaling 3 in keratinocytes causes skin inflammation mediated by interleukin-20 receptor-related cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343748

The suppressor of cytokine signaling (SOCS)-3 determines keratinocyte proliferative and migratory potential during skin repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343748

Constitutive SOCS-3 expression protects T-cell lymphoma against growth inhibition by IFNalpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343748

Constitutive expression of SOCS3 confers resistance to IFN-alpha in chronic myelogenous leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343748

The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343748

A three-dimensional model of Suppressor Of Cytokine Signalling 1 (SOCS-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343748

A SOCS-1 peptide mimetic inhibits both constitutive and IL-6 induced activation of STAT3 in prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343748

Both the suppressor of cytokine signaling 1 (SOCS-1) kinase inhibitory region and SOCS-1 mimetic bind to JAK2 autophosphorylation site: implications for the development of a SOCS-1 antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343748

New mimetic peptides of the kinase-inhibitory region (KIR) of SOCS1 through focused peptide libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343748

Skin immune sentinels in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343748

7 January 2021

Epithelial overexpression of SOCS-3 in transgenic mice exacerbates wound inflammation in the presence of elevated TGF-beta1

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343748

7 January 2021

Tumor necrosis factor alpha attenuates interferon alpha signaling in the liver: involvement of SOCS3 and SHP2 and implication in resistance to interferon therapy.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343748

7 January 2021

IFN-alpha antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling-3.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343748

7 January 2021

Suppressor of cytokine signaling 1 inhibits IFN-gamma inflammatory signaling in human keratinocytes by sustaining ERK1/2 activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343748

7 January 2021

Identifiers

DOI

10.1002/EJI.201343748

1 reference

16 December 2017

PubMed ID

23828297

1 reference

16 December 2017